Entity Address, City or Town
Entity Address, City or Town
Lease renewal term
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term
Entity Ex Transition Period
Entity Ex Transition Period
Fair Value Disclosures [Abstract]
Denominator
Earnings Per Share [Abstract]
Astrazeneca UK.
Astrazeneca UK [Member]
AstraZeneca UK
Equity financing costs
Payment of Equity Financing Costs
Payment of equity financing costs.
Two Thousand Twenty One Term Loan and Promissory Note One [Member]
Two Thousand Twenty One Term Loan and Promissory Note One [Member]
2021 Term Loan and Promissory Note One
Schedule of Accrued Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Direct Costs and Expenses
Direct Costs And Expenses [Member]
Direct costs and expenses.
Stock Issued During Period, Value, New Issues
Issuance of common stock, net
Aggregate offering price
Stock issuable per day, number of shares
Other Assets
Other Assets Policy Text Block
Other Assets Policy Text Block
Release of restricted stock units
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than OptionsVested In Period Amount
Share based compensation arrangement by share based payment award equity instruments other than optionsvested in period amount.
Cash flows from financing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase agreement term
Purchase Agreement Term
Purchase agreement term.
Intangible Assets, Gross (Excluding Goodwill), Total
Intangible assets, Cost
Intangible Assets, Gross (Excluding Goodwill)
Fair Value Measurement
Fair Value Measurement [Domain]
Long-term Line of Credit
Long-Term Line of Credit
Long-term Line of Credit, Total
Amendment Flag
Amendment Flag
Long Term Debt Maturities Repayments Of Principal In Year Five And Thereafter
Long term debt maturities repayments of principal in year five and thereafter.
2028 and thereafter
Long-Term Debt, Maturity, Year Four
2027
Noncash purchases of property and equipment
Capital Expenditures Incurred but Not yet Paid
Convertible Debt
Convertible Debt Securities [Member]
Subsequent Event Type [Domain]
Extinguishment of Debt [Axis]
Intangible assets subject to amortization, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Goodwill, Ending Balance
Goodwill, Beginning Balance
Goodwill, Total
Goodwill
Goodwill
Diagnostic Tests
Diagnostic Tests [Member]
Diagnostic tests.
Operating lease right-of-use assets
Right of use assets
Operating Lease, Right-of-Use Asset
Non‑current assets
Assets, Noncurrent [Abstract]
Long-term notes payable
Notes Payable, Noncurrent, Total
Long‑term notes payable, net of current portion
Notes Payable, Noncurrent
Document Quarterly Report
Document Quarterly Report
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
Operating leases, Less amount representing interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less amount representing interest
Aggregate Intrinsic Value, Granted
Share Based Compensation Arrangement By Share Based Payment Award Options Granted Aggregate Intrinsic Value
Share based compensation arrangement by share based payment award options granted aggregate intrinsic value.
To be paid on September 30 2022.
To Be Paid On September 30 2022 [Member]
To be paid on September 30, 2022
Statement [Table]
Statement [Table]
Long-term operating lease liabilities
Operating Lease, Liability, Noncurrent
Lessor reimbursements received.
Lessor Reimbursements Received
Lessor reimbursements received
Issuance of common stock under employee stock purchase plan, Shares
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Services
Service [Member]
Other Long-term Liabilities
Other Noncurrent Liabilities [Member]
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, outstanding
Preferred Stock, Shares Outstanding
Business Acquisition
Business Acquisition [Axis]
Number of shares reserved for issuance
Common Stock, Capital Shares Reserved for Future Issuance
Series B Preferred Stock
Series B Preferred Stock [Member]
Weighted Average Grant Date Fair Value Per Share, June 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance
Weighted average grant date fair value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Per Share, Released
Maximum percentage of common stock allowed to purchase by counterparty
Maximum Percentage of Common Stock Allowed to Purchase by Counterparty
Maximum percentage of common stock allowed to purchase by counterparty.
First Amendment [Member]
First Amendment.
First Amendment [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total
Stock Options, Forfeited/canceled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Product and Service
Product and Service [Axis]
Employee Stock Purchase Plan
Employee Stock [Member]
Fourth milestone payment and interest paid
Fourth milestone and interest payment made
Fourth milestone and interest payment made.
Subscription Agreements
Subscription Agreements Member
Subscription agreements.
Second Amendment
Second Amendment [Member]
Second amendment.
Employee-related Liabilities, Current, Total
Compensation related accruals
Employee-related Liabilities, Current
Concentration Risk Type
Concentration Risk Type [Axis]
Operating leases, Weighted-average remaining lease term (in years)
Operating Lease, Weighted Average Remaining Lease Term
Total liabilities and stockholders' (deficit) equity
Liabilities and Equity
Plan Name
Plan Name [Domain]
Number of Shares, Forfeited/canceled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Number of Shares, Forfeited/canceled
Other current liabilities
Other Liabilities, Current
Other Liabilities, Current, Total
Fair Value Adjustment of Warrants
Change in fair value of warrant liability
Change in fair value of warrant liability
Measurement Input, Discount Rate [Member]
Discount Rate
Minimum annual volume percentage thereafter
Minimum Annual Volume Percentage Thereafter
Minimum annual volume percentage thereafter.
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Income Statement [Abstract]
Board of Directors
Board of Directors Chairman [Member]
Lessee Operating Lease Liability Payments Due After Year Four
Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Operating leases, 2028 and thereafter
Share-Based Payment Arrangement, Tranche Three [Member]
Tranche C Loan
Organization and Description of Business
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Remaining estimated obligation
Remaining Estimated Obligation
Remaining estimated obligation.
Third Amendment
Third Amendment [Member]
Third amendment.
Sale of Stock
Sale of Stock [Domain]
Total current liabilities
Liabilities, Current
Lease agreement number of options to extend
Lease Agreement Number Of Options To Extend
Lease agreement number of options to extend
Percentage of royalty payments on net revenue
Percentage Of Royalty Payments On Net Revenue
Percentage of royalty payments on net revenue.
Issuance of common stock under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Series A2 Preferred Stock
Series A2 Preferred Stock [Member]
Series A-2 preferred stock.
Lessee, Operating Lease, Liability, to be Paid, Year Three
Operating leases, 2026
Business acquisition contingent consideration gross margin target
Cash Acquired from Acquisition
Business Acquisition, Acquiree
Business Acquisition, Acquiree [Domain]
United healthcare.
United Healthcare [Member]
United Healthcare
Fair Value, Recurring
Fair Value, Recurring [Member]
Interest Expense, Total
Interest expense
Interest Expense
Interest expense
Accounts Receivable, Allowance for Credit Loss, Ending Balance
Accounts Receivable, Allowance for Credit Loss, Beginning Balance
Allowance for doubtful accounts receivable
Accounts Receivable, Allowance for Credit Loss
Two Tranche
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche B Loan
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Summary of significant accounting policies.
Tenant improvement allowances received.
Tenant Improvement Allowances Received
Tenant improvement allowances received
Warrant Liabilities Fair Value Disclosure
Warrant Liabilities Fair Value Disclosure
Warrant liabilities
Common Stock Purchase Agreement
Common Stock Purchase Agreement Member
Common stock purchase agreement member.
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Operating leases, Less amount representing tenant improvement allowances
Lessee, operating lease, liability, amount representing tenant improvement allowances
Lessee, operating lease, liability, amount representing tenant improvement allowances.
Preferred stock, authorized
Preferred Stock, Shares Authorized
Other Long-term Assets
Other Noncurrent Assets [Member]
Percentage of royalty payments on net sales
Percentage Of Royalty Payments On Net Sales
Percentage of royalty payments on net sales.
Borrowings
Long-Term Debt, Fair Value
Warratns exercisable
Class of warrant or right, additional warrants or rights exercisable.
Class of Warrant or Right, Additional Warrants or Rights Exercisable
Additional warratns exercisable
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Weighted-average remaining lease term and discount rate associated with operating leases
Operating leases, Weighted-average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Gross proceeds from sale of common shares
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Funding amount
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
Proceeds from issuance of common stock under employee stock purchase plan.
Entity Small Business
Entity Small Business
Additional tenant improvement allowance amount.
Additional Tenant Improvement Allowance Amount
Additional Tenant improvement allowance
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Cash, cash equivalents, and restricted cash ‑ beginning of period
Cash, cash equivalents, and restricted cash ‑ end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Cash and cash equivalents and restricted cash
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Investments
Investments [Domain]
Series C Preferred Stock
Series C Preferred Stock [Member]
Debt Instrument, Redemption, Period
Debt Instrument, Redemption, Period [Domain]
Total current assets
Assets, Current
Property Plant And Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Indefinite-lived Intangible Assets
Indefinite-Lived Intangible Assets [Axis]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Operating leases, Remainder of 2022
Operating leases, Remainder of 2023
Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance
Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance
Indefinite-lived Intangible Assets (Excluding Goodwill), Total
Intangible assets not subject to amortization, Net Carrying Value
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items].
Weighted-average shares outstanding, basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
City Area Code
City Area Code
Aggregate Intrinsic Value, Outstanding - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate Intrinsic Value, Outstanding - January 1, 2023
Percentage of development and regulatory costs exercised using opt-out right
Percentage Of Development And Regulatory Costs Exercised Using Opt Out Right
Percentage of development and regulatory costs exercised using opt-out right.
Share-Based Payment Arrangement [Abstract]
Total liabilities
Liabilities
Private Placement
Private Placement [Member]
Document Period End Date
Document Period End Date
Year of ending royalty payments from first commercial sale
Year Of Ending Royalty Payments From First Commercial Sale
Year of ending royalty payments from first commercial sale.
Patent costs and intangible asset acquisition, net
Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net
Payments for proceeds from patent costs and intangible asset acquisition, net.
Schedule Of Finite Lived Intangible Assets [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Series E Convertible Preferred Stock Warrants
Series E Convertible Preferred Stock Warrants [Member]
Series E convertible preferred stock warrants.
Construction in Process
Construction in Progress [Member]
Weighted-average Lease Term and Discount Rates
Weighted Average Lease Term Discount Rate Finance Operating [Table Text Block]
Weighted average lease term discount rate finance operating.
Equity financing costs included in Accounts payable and other accrued liabilities.
Equity Financing Costs Included in Accounts Payable and Other Accrued Liabilities
Equity financing costs included in Accounts payable and other accrued liabilities
First Tranche
Share-Based Payment Arrangement, Tranche One [Member]
Tranche A Loan
Lease commencement date
Lease Commencement Date
Lease commencement Date
Software and Software Development Costs [Member]
Software
Non-current deferred revenue
Contract with Customer, Liability, Noncurrent
Finite-Lived Intangible Asset, Expected Amortization, Year One
2024
Statistical Measurement
Statistical Measurement [Axis]
Trademarks
Trademarks [Member]
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests
Percentage Of Revenue Share Payment Related To Acquired Diagnostic Test Recognized Revenue For Non Screening Tests
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests.
At-the-money Facility
At-the-money Facility [Member]
At-the-money facility.
Other current assets
Other Assets, Current
Schedule of Intangible Assets, Excluding Goodwill
Schedule of Intangible Assets and Goodwill [Table Text Block]
Subsequent Event [Line Items]
Shares issued or issuable, threshold limit description
Shares Issued or Issuable, Threshold Limit Description
Shares issued or issuable, threshold limit description.
Vehicles
Vehicles [Member]
Total assets
Assets
Series F Preferred Stock
Series F Preferred Stock [Member]
Securities Purchase Agreement
Securities Purchase Agreements [Member]
Securities purchase agreements.
Net loss per share, diluted
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Deposits [Member]
Schedule of Common Stock Equivalents Excluded from Diluted Net Loss Attributable to Common Stockholders
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Beginning balances
Ending balances
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Exit fee payment
Exit Fee Payment
Exit fee payment.
Class of Stock Disclosures [Abstract]
Revenue Share Agreement
Revenue Share Agreement [Member]
Revenue share agreement.
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Document Fiscal Period Focus
Document Fiscal Period Focus
Revenue share expenses
Revenue Share Expenses
Revenue share expenses.
Bonus-To-Options Program
Bonus To Options Program [Member]
Bonus-to-options program.
Bio-Rad License
Bio Rad License [Member]
Bio-rad license.
Restricted Cash, Total
Restricted cash
Restricted Cash
Class Of Warrant Or Right [Table]
Class of Warrant or Right [Table]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Deferred offering costs
Deferred Offering Costs
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued
Preferred stock, $0.001 par value, 5,000,000 authorized; 0 (2023 and 2022) issued and outstanding
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Share-based compensation
Counterparty Name
Counterparty Name [Domain]
Other Nonoperating Income
Other income, net
Operating lease liability
Operating Lease, Liability
Total lease liabilities
Net cash and cash equivalents and restricted cash (used in) provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Landlord contribution towards cost of construction and tenant improvements
Landlord Contribution Towards Cost of Construction and Tenant Improvements
Landlord contribution towards cost of construction and tenant improvements
Notes payable, total
Notes Payable
Statement of Financial Position [Abstract]
Convertible preferred stock, issued
Temporary Equity, Shares Issued
Changes in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Entity File Number
Entity File Number
Scenario [Domain]
Statement of Cash Flows [Abstract]
Weighted average exercise price, Granted
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price.
Balance Sheet Related Disclosures [Abstract]
Warrant issued to purchase shares
Warrant issued to purchase shares
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Deferred Revenue Arrangement Type
Deferred Revenue Arrangement Type [Axis]
Warrant issued to purchase shares
Warrants to purchase shares of common stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Ficlatuzumab
Ficlatuzumab [Member]
Ficlatuzumab.
Class Of Warrant Or Right [Line Items]
Class of Warrant or Right [Line Items]
Geographical [Domain]
Statistical Measurement
Statistical Measurement [Domain]
Statement of Stockholders' Equity [Abstract]
Sale of Stock
Sale of Stock [Axis]
Notes Payable, Current, Total
Less: current maturities
Notes Payable, Current
Class of Stock
Class of Stock [Domain]
Accrued legal contingency
Loss Contingency Accrual
Loss Contingency Accrual, Ending Balance
Loss Contingency Accrual, Beginning Balance
Revenue
Revenue Benchmark [Member]
Summary of Components of Lease Expense
Lease, Cost [Table Text Block]
Stockholders' Equity Note [Abstract]
Subsequent Events [Abstract]
Fair Value
Fair Value Disclosures [Text Block]
Number of blood based lung cancer test
Number Of Cancer Test
Number of cancer test.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted Average Contractual Life (Years), Exercisable - March 31, 2023
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
Proceeds from the issuance of common stock
Net proceeds
Proceeds from the sale of common shares
Proceeds from Issuance of Common Stock
Contingent consideration arrangements, common shares, redemption amount
Business Combination Contingent Consideration Arrangements Common Shares Redemption Amount
Business combination contingent consideration arrangements common shares redemption amount.
Long-term Debt, Type
Long-Term Debt, Type [Axis]
Series G Convertible Preferred Stock Warrants
Series G Convertible Preferred Stock Warrants [Member]
Series G convertible preferred stock warrants.
Prior to First Anniversary
Debt Instrument, Redemption, Period One [Member]
Initial warrants amount.
Initial warrants amount
Initial warrants amount
Schedule of Property and Equipment
Property, Plant and Equipment [Table Text Block]
Reduction in contingent consideration
Reduction in contingent consideration
Other
Proceeds from (Payments for) Other Financing Activities
Revenue and Accounts Receivable Credit Concentration
Revenue from Contract with Customer [Text Block]
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentrations of Credit Risk and Other Uncertainties
Antidilutive Securities
Antidilutive Securities [Axis]
Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration]
Restricted Cash, Current, Statement of Financial Position [Extensible Enumeration]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Summary of Activity for Convertible Preferred Stock Warrants Outstanding
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Deferred revenue
Contract with Customer, Liability, Current
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Remainder of 2023
Lessee, Lease, Description [Line Items]
Supplementary Balance Sheet Information
Supplemental Balance Sheet Disclosures [Text Block]
Credit Facility [Domain]
Subsequent Events
Subsequent Events [Text Block]
Weighted-average shares outstanding, diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Cash collateralized letter of credit member.
Cash Collateralized Letter of Credit [Member]
Cash Collateralized Letter of Credit
Adjustments to additional paid-in capital deferred offering costs
Adjustments to additional paid-in capital deferred offering costs.
Finite-Lived Intangible Assets, Major Class Name
Finite-Lived Intangible Assets, Major Class Name [Domain]
Credit Facility [Axis]
Remaining unrecognized share based compensation expense for options and restricted stock units
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Portion at Fair Value Measurement [Member] [Default]
Fair Value Disclosure Item Amounts [Default]
Portion at Fair Value Measurement [Member]
Royalty expense
Royalty Expense
Computer Equipment
Computer Equipment [Member]
Inventory
Inventory Supplies, Policy [Policy Text Block]
Current Fiscal Year End Date
Current Fiscal Year End Date
Investment Type
Investment Type [Axis]
Industry Sector
Industry Sector [Axis]
Issuance of common stock for deferred offering costs, Shares
Stock Issued During Period, Shares, For Deferred Offering Costs
Stock issued during period, shares, for deferred offering costs.
PPP Loan
P P P Loan [Member]
PPP loan.
Liability Class
Liability Class [Axis]
Fourth Amendment to 2021 Term Loan
Fourth amendment to 2021 term loan [Member]
Fourth amendment to 2021 term loan.
Depreciation, Total
Depreciation expense
Depreciation
Financial Instruments [Domain]
Other Assets, Noncurrent, Total
Other long-term assets
Other Assets, Noncurrent
Entity Address, Address Line One
Entity Address, Address Line One
Repayments of Long-term Debt, Total
Repayment of term loan and notes payable
Repayments of Long-Term Debt
Amount used to retire outstanding debt
Series H Convertible Preferred Stock
Series H Preferred Stock [Member]
LPC Facility
L P C Facility [Member]
LPC facility.
The State of Colorado
The State of Colorado Member
The State of Colorado.
Finite-Lived Intangible Assets by Major Class
Finite-Lived Intangible Assets by Major Class [Axis]
Supplemental cash flow information:
Supplemental Cash Flow Information [Abstract]
Recently Issued Accounting Standards
Accounting Standards Update and Change in Accounting Principle [Text Block]
Percentage of interest on installment payments
Percentage Of Interest On Contingent Consideration
Percentage of interest on contingent consideration.
Contingent Consideration Type
Contingent Consideration Type [Domain]
Income Tax Expense (Benefit), Total
Provision for income taxes
Income Tax Expense (Benefit)
Public offering price per share of common stock.
Public offering price per share of common stock
Public offering price per share of common stock
Current and long-term operating lease liabilities
Increase (Decrease) in Operating Lease Liability
Weighted average exercise price, Outstanding - September 30, 2020, warrants
Weighted average exercise price, Outstanding - January 1, 2020, warrants
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price.
Weighted Average Exercise Price, Forfeited/canceled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Income Taxes
Income Tax Disclosure [Text Block]
Vesting [Axis]
Preferred Stock, Shares Issued, Total
Preferred stock, issued
Preferred Stock, Shares Issued
Balance Sheet Location
Balance Sheet Location [Domain]
Other expenses
Other Accrued Liabilities, Current
Prior to Second Anniversary
Debt Instrument, Redemption, Period Two [Member]
Purchases of property & equipment included in Accrued liabilities
Payments to Acquire Property, Plant, and Equipment, Total
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Income Tax Disclosure [Abstract]
Number of quarterly installment
Contingent consideration number of installments
Business Acquisition Contingent Consideration Number Of Installments
Business acquisition contingent consideration number of installments.
Original issue discount associated with Promissory Note One
Original issuance discount
Original issuance discount.
Fourth milestone payment and interest
Fourth milestone payment and interest
Fourth milestone payment and interest.
Number of commercial blood-based test
Number Of Commercial Blood Based Test
Number of commercial blood based test.
Measurement Input, Expected Dividend Rate [Member]
Dividend Yield
Shares of common stock issued and sold
Stock Issued During Period, Shares, New Issues
Issuance of common stock, net, Shares
Leased property building capacity
Leased Property Building Capacity
Leased property building capacity.
Carrying Value
Reported Value Measurement [Member]
At-The-Market Offering
At The Market Offering [Member]
At The Market Offering [Member]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Deferred offering costs
Payment Of Deferred Offering Costs
Payment of deferred offering costs.
Business combination contingent consideration final payment
Business Combination Contingent Consideration Final Payment
Business combination contingent consideration final payment.
Summary of Future Minimum Lease Payments for Operating Lease Obligations
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Revenue recognized
Contract with Customer, Liability, Revenue Recognized
Accounts Payable
Accounts Payable [Member]
Loss from operations
Operating Income (Loss)
2021 Term Loan
Two Thousand Twenty One Term Loan [Member]
Two thousand twenty one term loan.
Debt Instrument, Interest Rate, Stated Percentage
Interest rate
Shares issued
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Number of Shares, Outstanding - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Number of Shares, Outstanding - January 1, 2023
Total non‑current liabilities
Liabilities, Noncurrent
Proceeds from term loan and notes payable
Proceeds From Issuance Of Term Loan And Notes Payable
Proceeds from issuance of term loan and notes payable.
Other
Other [Member]
Other member.
Payments to Acquire Businesses, Net of Cash Acquired, Total
Contingent consideration cash payment
Payments to Acquire Businesses, Net of Cash Acquired
Scenario [Axis]
Promissory Note Two
Promissory Note Two [Member]
Promissory note two.
ATM Facility
At The Market Facility [Member]
At the market facility.
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Business acquisition contingent consideration gross margin target period
Business Acquisition Contingent Consideration Gross Margin Target Period
Business acquisition contingent consideration gross margin target period.
Class of Warrant or Right
Class of Warrant or Right [Domain]
Entity Filer Category
Entity Filer Category
Non‑current liabilities
Liabilities, Noncurrent [Abstract]
Capital expenditure for leasehold improvements related to leases premises which are tenant improvements
Tenant Improvements
Issuance of common stock for deferred offering costs
Stock Issued During Period, Values, For Deferred Offering Costs
Stock issued during period, values, for deferred offering costs.
Total operating expenses
Operating Expenses
Fair Value by Liability Class
Fair Value by Liability Class [Domain]
Entity Current Reporting Status
Entity Current Reporting Status
Additional warrants amount.
Additional warrants amount
Additional warrants amount
Interest expense
Fair Value Measurement With Unobservable Inputs Interest Expense
Fair value measurement with unobservable inputs interest expense.
Accrued interest, amortization of debt issuance costs and other
Accrued Interest Amortization Of Debt Issuance Costs And Other
Accrued interest, amortization of debt issuance costs and other.
Aggregate Intrinsic Value, Exercisable - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Lease option to extend
Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false]
Current Portion of Contingent Consideration
Current Portion Of Contingent Consideration [Member]
Current portion of contingent consideration.
Equity
Stockholders' Equity Note Disclosure [Text Block]
Total
Intangible assets subject to amortization, Net Carrying Value
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net, Beginning Balance
Finite-Lived Intangible Assets, Net
Total stockholders' (deficit) equity
Balances
Balances
Stockholders' Equity Attributable to Parent
Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842.
Operating Lease Right-of-Use Assets Obtained in Exchange for Lease Liabilities at Adoption of ASC 842
Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842
Shares issued as commitment fee, value
Shares Issued as Commitment Fee, Value
Shares issued as commitment fee, value.
Long-Term Debt, Maturity, Year Two
2025
Entity Tax Identification Number
Entity Tax Identification Number
Income Statement Location
Income Statement Location [Axis]
Common stock, $0.001 par value, 200,000,000 authorized; 78,610,663 (2023) and 77,614,358 (2022) shares issued and outstanding
Aggregate market value of common stock and other equity securities
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Reserve for inventory
Inventory Valuation Reserves
Lab Equipment
Equipment [Member]
Fair Value Liabilities Measured On Recurring Basis [Table]
Fair Value Liabilities Measured On Recurring Basis [Table]
Disclosure of information about liabilities measured at fair value on recurring basis.
Equity Components
Equity Components [Axis]
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
OID and debt issuance costs
Unamortized debt discount and debt issuance costs
Series E Preferred Stock
Series E Preferred Stock [Member]
Number of preferred stock converted into common stock
Number Of Preferred Stock Converted Into Common Stock
Number of preferred stock converted into common stock.
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
2018 Notes
Notes Payable2018 Notes [Member]
Notes payable 2018 notes.
Tenant improvement allowances expected to be received.
Tenant improvement allowances expected to be received
Leases [Abstract]
Promissory notes.
Promissory Notes Member
Promissory Notes
Debt Instruments [Abstract]
Disaggregation Of Revenue [Table]
Disaggregation of Revenue [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Warrants expiration date
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Accounts payable and other accrued liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Entity Emerging Growth Company
Entity Emerging Growth Company
Purchase Commitment, Excluding Long-Term Commitment [Domain]
Operating expenses:
Operating Expenses [Abstract]
Direct costs and expenses
Direct Costs And Expenses
Direct costs and expenses.
Measurement Input, Price Volatility [Member]
Volatility
Percentage of fee payments on net sales
Percentage Of Fee Payments On Net Sales
Percentage of fee payments on net sales.
Issuance of warrants
Adjustments to Additional Paid in Capital, Warrant Issued
CARES Act
C A R E S Act [Member]
CARES act.
Schedule Of Stock By Class [Table]
Schedule of Stock by Class [Table]
Letter of Credit
Letter of Credit [Member]
2021 Term Loan partial repayment in April 2022 member.
2021 Term Loan Partial Repayment in April 2022
Two Thousand and Twenty One Term Loan Partial Repayment in April 2022 [Member]
Percentage of license income generated from licensing
Percentage of license income generated from licensing
Percentage Of License Income Generated From Licensing
Percentage of license income generated from licensing.
Lessee, Operating Lease, Liability, to be Paid [Abstract]
COLORADO
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Document Transition Report
Document Transition Report
Long-Term Debt, Maturity, Year Three
2026
Third amendment to 2021 term loan member.
Third Amendment to 2021 Term Loan
Third Amendment to 2021 Term Loan [Member]
Weighted Average Grant Date Fair Value Per Share, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Intangible assets not subject to amortization, Cost
Indefinite Lived Intangible Assets Excluding Goodwill Gross
Indefinite lived intangible assets excluding goodwill gross.
Responsible percentage of development and regulatory costs
Percentage Of Development And Regulatory Costs
Percentage of development and regulatory costs.
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Weighted Average Exercise Price, Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Accounts receivable, net of allowance for doubtful accounts of $150 and $118
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts Receivable, after Allowance for Credit Loss, Current
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Number of facility
Number of Facility
Number of facility.
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Description of offering period under plan
Description Of Offering Period Under Plan
Description of offering period under plan.
Loss
Loss [Member]
Loss member.
Net loss attributable to common stockholders
Net loss
Net loss
Net Income (Loss) Attributable to Parent
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Current portion of operating lease liabilities
Operating Lease, Liability, Current
Number of SARS-CoV-2 test
Number Of S A R S Co V2 Test
Number of SARS-CoV-2 test.
2021 Term Loan Principal Repayment
Two Thousand Twenty One Term Loan Principal Repayment [Member]
Two thousand twenty one term loan principal repayment.
Issuance of Perceptive Warrants
Issuance of Perceptive Warrants
Issuance of perceptive warrants.
Base rent per month from commencement date
Base Rent Per Month From Commencement Date
Base rent per month from commencement date.
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Summary of Restricted Stock Units Activity
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Initial fairvalue of additional warrants
Scheduled Principal Repayments (Maturities) of Long-term Obligations
Schedule of Maturities of Long-Term Debt [Table Text Block]
Contingent Consideration
Contingent Consideration [Member]
Contingent consideration.
Entity Registrant Name
Entity Registrant Name
Liabilities, Fair Value Disclosure, Total
Total contingent consideration
Liabilities, Fair Value Disclosure
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Net Loss per Common Share
Earnings Per Share [Text Block]
Estimated payment to third parties
Estimated Payment To Third Parties
Estimated payment to third parties.
Convertible Preferred Stock
Class of Stock [Axis]
Debt instrument maturity date
Debt Instrument, Maturity Date
Lessee, Lease, Description [Table]
Revenues, Total
Revenues
Revenues
Share-based Payment Arrangement, Noncash Expense, Total
Share-Based Payment Arrangement, Noncash Expense
Share-based compensation expense
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Total property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Debt Instrument, Unamortized Discount, Total
Debt Instrument, Unamortized Discount
Debt instrument, discount
Award Type
Award Type [Domain]
Statement [Line Items]
Statement [Line Items]
Series A3 Preferred Stock
Series A3 Preferred Stock [Member]
Series A-3 preferred stock.
Operating lease expense
Operating Lease, Expense
Purchases of property & equipment included in Accrued liabilities
Purchases Of Property And Equipment Included In Accrued Liabilities
Purchases of property and equipment included in accrued liabilities.
Warrant liability.
Warrant Liability [Member]
Warrant Liability
Warrant Liabilities
Accounting Standards Update and Change in Accounting Principle [Abstract]
Title of 12(b) Security
Title of 12(b) Security
Finite-Lived Intangible Assets, Gross, Total
Intangible assets subject to amortization, Cost
Finite-Lived Intangible Assets, Gross
Common Stock
Common Stock [Member]
Net proceeds after deducting estimated offering expenses
Sale of Stock, Consideration Received on Transaction
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Cash flows from operating activities
Net Cash Provided by (Used in) Operating Activities [Abstract]
Equity Component
Equity Component [Domain]
Fair Value of Financial Instruments
Fair Value Measurement, Policy [Policy Text Block]
Convertible Preferred Stock
Convertible Preferred Stock [Member]
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
Entity Address, State or Province
Entity Address, State or Province
Lessee, Operating Lease, Liability, to be Paid, Year Four
Operating leases, 2027
Geographical [Axis]
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net decrease in cash and cash equivalents and restricted cash
Document Type
Document Type
Interest Paid, Excluding Capitalized Interest, Operating Activities
Cash paid for interest
Warrants to Purchase Convertible Preferred Stock
Warrants For Convertible Preferred Stock [Text Block]
Warrants for convertible preferred stock.
Lease expiration date
Lease Expiration Month Year
Lease expiration month year
Entity Shell Company
Entity Shell Company
Collateral Held [Domain]
Total share-based compensation expense
Stock compensation expense
Share-Based Payment Arrangement, Expense
Percentage of royalty payments not required on net revenue
Percentage Of Royalty Payments Not Required To Pay On Net Revenue
Percentage of royalty payments not required to pay on net revenue.
Inventory
Other Inventory, Supplies, Gross
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Stock issuable per day, number of shares
Sale of Stock, Stock Issuable Per Day, Shares
Sale of stock, stock issuable per day, shares.
Operating Leases, Rent Expense, Net, Total
Rent expense
Operating Leases, Rent Expense, Net
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Security Exchange Name
Security Exchange Name
Revenue from Contract with Customer [Abstract]
Class Of Stock [Line Items]
Class of Stock [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Net Cash Provided by (Used in) Operating Activities
Net cash and cash equivalents and restricted cash used in operating activities
Amortized to expense period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted Average Contractual Life (Years), Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Debt Instrument, Interest Rate, Effective Percentage
Effective interest rate
Interest expense due to passage of time and fixed payment schedule.
Interest expense due to passage of time and fixed payment schedule
Commitments and Contingencies Disclosure [Abstract]
Centennial Valley Properties I, LLC Lease Agreement
Centennial Valley Properties I, LLC
Centennial Valley Properties I, LLC Lease Agreement [Member]
Centennial Valley Properties I, LLC Lease Agreement.
Measurement Input, Expected Term [Member]
Expected Term
Restricted Stock Units
Restricted Stock Units (RSUs)
Restricted Stock Units (RSUs) [Member]
Summary of Future Minimum Lease Payments for Operating Leases
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Tenant improvements incurred during the period.
Tenant Improvements Incurred During The Period
Tenant improvements incurred during the period
Warrants
Warrant [Member]
Summary of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Recently Adopted Accounting Standards
New Accounting Pronouncements, Policy [Policy Text Block]
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, outstanding
Common Stock, Shares, Outstanding
Loss on extinguishment of liabilities, net
Loss on extinguishment of liabilities, net
Loss on extinguishment of liabilities
Gain (Loss) on Extinguishment of Debt, Total
Gain (Loss) on Extinguishment of Debt
Loss on debt extinguishment
Debt
Debt Disclosure [Text Block]
Term of royalty payments from first commercial sale
Term Of Royalty Payments From First Commercial Sale
Term of royalty payments from first commercial sale.
Subscription agreements description
Subscription Agreements Description
Subscription agreements description.
Deferred offering costs included in Accrued liabilities
Deferred Offering Costs Included In Accrued Liabilities
Deferred offering costs included in accrued liabilities.
Level 2
Fair Value, Inputs, Level 2 [Member]
2020 Equity Incentive Plan
Two Thousand Twenty Equity Incentive Plan [Member]
2020 equity incentive plan.
Cash flows from investing activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Options and Restricted Stock Units (RSUs)
Options And Restricted Stock Units R S Us [Member]
Options and restricted stock units (RSUs).
Promissory Note One
Promissory Note One [Member]
Promissory note one.
Schedule of Future Estimated Amortization Expense of Intangible Assets
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Commitments and contingencies
Commitments and Contingencies
Common Stock, Shares, Issued, Total
Common stock, issued
Common Stock, Shares, Issued
Exercised, warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Common stock issued for deferred offering costs
Common Stock Issued For Deferred Offering Costs
Common stock issued for deferred offering costs.
Minimum
Minimum [Member]
After Second Anniversary, Prior to October 19, 2025
Debt Instrument, Redemption, Period Three [Member]
Rent after fixed escalation provisions
Rent After Fixed Escalation Provisions
Rent after fixed escalation provisions.
Final settlement payment of legal contingency
Loss Contingency Accrual, Payments
Restricted cash deposits
Restricted Cash, Current
Proceeds from net of debt issuance costs and original issue discounts
Proceeds from Debt, Net of Issuance Costs
Net proceeds from debt, after deducting debt issuance costs and expenses
Patents
Patents [Member]
Lessee, Leases [Policy Text Block]
Leases
Weighted Average Exercise Price, Exercisable - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Total accrued liabilities
Accrued liabilities
Accrued Liabilities, Current
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance
Weighted Average Grant Date Fair Value Per Share, January 1, 2023
Deferred Revenue
Deferred Revenue [Domain]
Debt Instrument
Debt Instrument [Axis]
Stockholders' equity
Stockholders' Equity Attributable to Parent [Abstract]
Counterparty Name
Counterparty Name [Axis]
Entity Address, Address Line Two
Entity Address, Address Line Two
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range
Percentage Of Probabilities Of Contingent Consideration Successful Achievement Milestone Discount Rates Range
Percentage of probabilities of contingent consideration successful achievement milestone discount rates range.
Weighted Average Grant Date Fair Value Per Share, Forefeited/canceled
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Lease description
Lessee, Operating Lease, Lease Not yet Commenced, Description
Amortization of Intangible Assets, Total
Amortization expense of definite-lived intangible assets
Amortization of Intangible Assets
Award Type
Award Type [Axis]
Subsequent Event
Subsequent Event [Member]
Loss Contingencies [Table]
Loss Contingencies [Table]
Milestone payment
Milestone payment.
Other Nonoperating Income (Expense)
Total other expense
Maturities of Long-Term Debt [Abstract]
Options to Purchase Common Stock
Options To Purchase Common Stock [Member]
Options to purchase common stock.
Organization And Description Of Business [Abstract]
Organization and description of business.
Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received
Remaining capacity under tenant improvement allowances prior to reimbursements expected to be received.
Payments of contingent consideration
Fair Value Measurement with Unobservable Inputs Payments of Contingent Consideration
Fair value measurement with unobservable inputs payments of contingent consideration.
Payments of contingent consideration
Private placement in net equity proceeds
Aggregate purchase price
Proceeds from Issuance of Private Placement
Cash Collateralized
Cash Collateralized [Member]
Cash collateralized.
Summary of Fair Value of Outstanding Borrowings
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]
Research and Development Expense, Total
Research and development
Research and Development Expense
Operating leases, Total future minimum lease payments
Lessee, Operating Lease, Liability, to be Paid
Payment of contingent consideration
Payment for Contingent Consideration Liability, Financing Activities
Operating lease, expiration term
Lessee, Operating Lease, Term of Contract
Entity Central Index Key
Entity Central Index Key
Other (expense) income:
Other Income and Expenses [Abstract]
Lincoln Park
Lincoln Park Member
Lincoln Park.
Warrants, expires period
Warrants and Rights Outstanding, Maturity Date
CellCarta License
Cell Carta License [Member]
CellCarta License.
Contingent consideration
Business Combination, Contingent Consideration, Liability, Noncurrent
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Schedule of future minimum Rental payments for operating and finance leases.
Summary of Future Minimum Lease Payments for Operating and Finance Leases
Summary of Future Minimum Rental Payments for Operating and Financing Leases
Schedule of Future Minimum Rental Payments for Operating and Finance Leases
Numerator
Net Income (Loss) Attributable to Parent [Abstract]
Convertible Preferred Stock
Preferred Stock [Text Block]
Finance lease right-of-use assets obtained in exchange for lease liabilities
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Customer
Customer [Axis]
Accounting Policies [Abstract]
Interest-bearing Deposits
Interest-Bearing Deposits [Member]
Debt Instrument, Redemption, Period
Debt Instrument, Redemption, Period [Axis]
Disaggregation Of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Less: accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Schedule Of Property Plant And Equipment [Table]
Property, Plant and Equipment [Table]
Supplemental Cash Flow Information Associated with Leasing Activities
Supplemental Cash Flow Information Leases Operating and Finance [Table Text Block]
Supplemental cash flow information leases operating and finance.
Third Amendment to APA Agreement
Third Amendment to APA Agreement [Member]
Third amendment to APA agreement member.
Measurement Frequency
Measurement Frequency [Axis]
Common stock remained available for future issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
Accretion of lease liability.
Accretion Of Lease Liability
Accretion of lease liability
Current portion of contingent consideration
Business Combination, Contingent Consideration, Liability, Current
Subsequent Event [Table]
Period of escalations of sales
Period Of Escalations Of Sales
Period of escalations of sales.
Measurement Input Type [Domain]
Weighted Average Exercise Price, Outstanding - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding - January 1, 2023
Research and Development
Research and Development Expense [Member]
Other current assets
Increase (Decrease) in Other Current Assets
Warrants and Rights Outstanding, Measurement Input
Warrants and rights outstanding, measurement input
Leases
Lessee Operating and Finance Leases [Text Block]
Lessee operating and finance leases.
Scenario Forecast
Forecast [Member]
Current portion of notes payable
Notes Payable to Bank, Current
Operating lease right-of-use assets obtained in exchange for lease liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Accumulated Deficit
Retained Earnings [Member]
Series B1 Convertible Preferred Stock
Series B1 Convertible Preferred Stock [Member]
Series B-1 Convertible Preferred Stock.
Extinguishment of Debt, Type [Domain]
Net proceeds
Net proceeds from sale of common shares after deducting underwriting discounts and commissions and offering expenses
Proceeds From Issuance Of Common Stock Net
Proceeds from issuance of common stock net.
License expiry date
License Agreement Expiry Date
License agreement expiry date.
Customer
Customer [Domain]
Segment Reporting [Abstract]
Principal Repayment
Principal Repayment [Member]
Principal repayment member.
Debt issuance costs included in Accounts payable and other accrued liabilities.
Debt Issuance Costs Included in Accounts Payable and Other Accrued Liabilities
Deferred issuance costs included in Accounts payable and other accrued liabilities
Measurement Input Type [Axis]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Industry Sector
Industry Sector [Domain]
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Total
Property and equipment, gross
Property, Plant and Equipment, Gross
Series D Preferred Stock
Series D Preferred Stock [Member]
Area of office space leased
Area of Office Space Leased
Area of office space leased.
Additional Paid in Capital, Ending Balance
Additional Paid in Capital, Beginning Balance
Additional Paid in Capital, Total
Additional paid‑in capital
Additional Paid in Capital
Entity Interactive Data Current
Entity Interactive Data Current
Lease term
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract
KANSAS
Lessee, Operating Lease, Liability, to be Paid, Year One
Operating leases, 2023
Operating leases, 2024
Existing Shareholders
Shareholders
existing shareholders member
existing shareholders.
Prepayment premium percentage of aggregate outstanding principal amount.
Prepayment premium percentage of aggregate outstanding principal amount
Prepayment premium percentage of aggregate outstanding principal amount
Provision for doubtful accounts
Accounts Receivable, Credit Loss Expense (Reversal)
Leasehold Improvements
Leasehold Improvements [Member]
Convertible preferred stock, outstanding
Temporary Equity Balance, Shares
Temporary Equity Balance, Shares
Temporary Equity, Shares Outstanding
Local Phone Number
Local Phone Number
Repurchase
Repurchase [Member]
Repurchase.
Schedule of Computation of Basic and Diluted Loss per Share Attributable to Stockholders
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Debt Disclosure [Abstract]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Weighted average exercise price, Forfeited/canceled
Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Share based compensation arrangement by share based payment award non-options forfeitures and expirations in period weighted average exercise price.
Stock Options Exercisable - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Description of lease
Lessee, Operating Lease, Description
Warrants and Rights Note Disclosure [Abstract]
IPO
Initial Public Offering
IPO [Member]
Summary of Revenue
Disaggregation of Revenue [Table Text Block]
Stock Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Other Liabilities, Noncurrent, Total
Other long-term liabilities
Other Liabilities, Noncurrent
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Changes in Contingent Consideration and Warrant Liabilities
Reverse stock split ratio
Stockholders' Equity Note, Stock Split, Conversion Ratio
Other Current Assets
Other Current Assets [Member]
Intangible assets, Accumulated Amortization
Intangible Assets Accumulated Amortization Excluding Goodwill
Amount of accumulated amortization of intangible assets, excluding goodwill.
Income Statement Location
Income Statement Location [Domain]
Interest rate on extra allowance amount
Interest Rate on Extra Allowance Amount
Interest rate on extra allowance amount
Measurement Input, Risk Free Interest Rate [Member]
Risk-Free Interest Rate
Long-Term Debt, Maturity, Year One
2024
Sales, Marketing, General and Administrative
Selling, General and Administrative Expenses [Member]
Total non‑current assets
Assets, Noncurrent
Long-Term Debt
Total
Common Stock Balance, Shares
Common Stock Balance, Shares
Shares, Outstanding
Remaining available capacity for share issuance
Line of Credit Facility, Remaining Borrowing Capacity
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Thereafter
Debt Instrument, Redemption, Period Four [Member]
Contingent Consideration by Type
Contingent Consideration by Type [Axis]
Customer Concentration Risk
Customer Concentration Risk [Member]
Operating Expense
Operating Expense [Member]
Stock Options, Outstanding - June 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Stock Options, Outstanding - January 1, 2023
Price per share
Share Price
Perceptive term loan member.
Perceptive Term Loan [Member]
Perceptive Term Loan Facility
Perceptive Term Loan Facility
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Reported Fair values of Contingent Consideration and Warrant Liabilities
Debt Instrument, Name
Debt Instrument, Name [Domain]
Shares Committed Under ESPP
Shares Committed Under E S P P [Member]
Shares committed under ESPP.
Document Fiscal Year Focus
Document Fiscal Year Focus
Intangible assets, Net Carrying Value
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Repayments of debt
Repayments of Debt
Repayments of Debt
Class of Warrant or Right
Class of Warrant or Right [Axis]
Payment of debt issuance costs
Payments of Debt Issuance Costs
Lessee, Operating Lease, Liability, to be Paid, Year Two
Operating leases, 2025
Vesting [Domain]
Net loss per share, basic
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Cash paid for income taxes
Income Taxes Paid
Assets
Assets [Abstract]
Debt Instrument, Annual Principal Payment
Aggregate principal amount outstanding
Summary of Long-term Notes Payable
Schedule of Long-Term Debt Instruments [Table Text Block]
Debt instrument, aggregate principal amount
Debt Instrument, Face Amount
Integrated Diagnostics Asset Purchase Agreement
Integrated Diagnostics Asset Purchase Agreement [Member]
Integrated diagnostics asset purchase agreement member.
Litigation Claims and Assessments
Litigation Claims And Assessments [Member]
Litigation claims and assessments.
Financial Instrument [Axis]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Axis]
Concentration Risk Benchmark
Concentration Risk Benchmark [Axis]
Liabilities and Stockholders' (Deficit) Equity
Liabilities and Equity [Abstract]
Impairment loss on intangible assets
Impairment of Intangible Assets, Finite-Lived
Income Taxes Paid, Net, Total
Cash paid for income taxes
Income Taxes Paid, Net
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
AVEO Oncology
A V E O Oncology [Member]
Aveo oncology.
Integrated Diagnostics, Inc
Integrated Diagnostics Inc [Member]
Integrated Diagnostics, Inc.
Current assets
Assets, Current [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Four
2027
Finite-Lived Intangible Asset, Expected Amortization, Year Two
2025
Warrant, exercise price
Warrant, exercise price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Contingent consideration shares
Business Combination Contingent Consideration Shares
Business combination contingent consideration shares.
Refundable deposit
Customer Funds
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Commitment shares issuable on conditional basis
Commitment Shares Issuable on Conditional Basis
Commitment shares issuable on conditional basis.
Inventory excess and obsolescence
Inventory Write-down
Excess and obsolete inventory
Measurement Frequency
Measurement Frequency [Domain]
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Number of Shares, Granted
Granted, warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted
Area of leased premised obligated to pay base rent
Area of Leased Premised Obligated to Pay Base Rent
Area of leased premised obligated to pay base rent.
Stock issuable per day, value
Sale of Stock, Stock Issuable Per Day, Value
Sale of Stock, stock issuable per day, value.
Diligence expense and legal fees.
Diligence Expense and Legal Fees
Diligence expenses and legal fees
Cover [Abstract]
Concentration risk, percentage
Concentration Risk, Percentage
Product and Service
Product and Service [Domain]
Accrued clinical trial expense
Accrued Clinical Trial Expense Current
Accrued clinical trial expense current.
Measurement Basis
Measurement Basis [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of Shares, Released
Number of Shares, Released
Release of restricted stock units, shares
Current liabilities
Liabilities, Current [Abstract]
Up Front Cash Payments
Up-front Payment Arrangement [Member]
Shares issued as commitment fee
Sale of Stock, Shares Issued as Commitment Fee
Sale of stock, shares issued as commitment fee.
Maximum
Maximum
Maximum [Member]
Warrants and Rights Outstanding, Term
Warrants expected term
Summary of Share-based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Series G Preferred Stock
Series G Preferred Stock [Member]
Forfeited/canceled, warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Net Cash Provided by (Used in) Investing Activities
Net cash and cash equivalents and restricted cash used in investing activities
Furniture and Fixtures
Furniture and Fixtures [Member]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Stock Options, Exercised
Exercise of stock options, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Collateral Held [Axis]
Level 3
Fair Value, Inputs, Level 3 [Member]
Primary sources of revenue, description
Primary Sources Of Revenue Description
Primary sources of revenue description.
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Purchased Technology
Purchased Technology [Member]
Purchased technology.
Debt Instrument, Basis Spread on Variable Rate
Applicable margin rate
Purchase Commitment, Excluding Long-Term Commitment [Axis]
Accounts Receivable
Accounts Receivable [Member]
Long-Term Debt, Maturity, Remainder of Fiscal Year
Remainder of 2023
Exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
Business acquisition description
Business Acquisition, Description of Acquired Entity
Weighted average price per share.
Weighted Average Price Per Share
Weighted average price per share
Notes/Loan payable
Long-Term Debt, Gross
Finite-Lived Intangible Asset, Expected Amortization, Year Three
2026
Common stock, authorized
Common Stock, Shares Authorized
NSCLC POC Trial
N S C L C P O C Trial [Member]
Nsclc poc trial.
2021 Term Loan Partial Repayment
2021 Term Loan Partial Repayment [Member]
2021 term loan partial repayment.
Trading Symbol
Trading Symbol
Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter
Finite lived intangible assets amortization expense year five and thereafter.
2028 and thereafter
Common stock issuable, committed to purchase
Stock Issuable During Period, Value, Committed Shares
Stock issuable during period, value, committed shares.
Interest Expense
Interest Expense [Member]
2021 Term Loan Amendment
Two Thousand Twenty One Term Loan Amendment [Member]
Two Thousand Twenty One Term Loan Amendment.
Selling, General and Administrative Expense, Total
Sales, marketing, general and administrative
Selling, General and Administrative Expense
Title of Individual [Domain]
Subsequent Event Type [Axis]
Weighted average exercise price, Exercised
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Share based compensation arrangements by share based payment award non options exercises in period weighted average exercise price.
Amortization of lease right-of-use assets
Amortization of operating lease right-of-use assets
Operating Lease, Right-of-Use Asset, Amortization Expense
Balance Sheet Location
Balance Sheet Location [Axis]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Perceptive term loan facility.
Perceptive Term Loan Facility [Member]
Perceptive Term Loan Facility
Plan Name
Plan Name [Axis]
Title of Individual [Axis]
Concentration Risk Type
Concentration Risk Type [Domain]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Domain]
Equity Financing Programs
Equity Financing Programs [Member]
Equity Financing Programs.
Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Common stock, par value
Common Stock, Par or Stated Value Per Share
Deferred offering costs amortized against Additional paid-in capital
Deferred Offering Costs Amortized Against Additional Paid-In Capital
Deferred offering costs amortized against additional paid-in capital.
Medicare
Medicare [Member]
Medicare.
Minimum cash balance at maturity date.
Minimum cash balance at maturity date
Minimum cash balance at maturity date
Series A-1 Preferred Stock
Series A1 Preferred Stock [Member]
Series A-1 preferred stock.
Oncimmune Limited
Oncimmune Limited [Member]
Oncimmune Limited.
Weighted Average Exercise Price, Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Fair Value
Estimate of Fair Value Measurement [Member]
Number of Shares, Outstanding - March 31, 2022
Number of Shares, Outstanding - January 1, 2022
Restricted stock units outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Long-term Debt, Type
Long-Term Debt, Type [Domain]
Total
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Concentration Risk [Table]
Concentration Risk [Table]
Indefinite-lived Intangible Assets, Major Class Name
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Other long-term assets
Increase (Decrease) in Other Noncurrent Assets